Bill Wexler's Profits of DOOM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote (555)	3/31/1998 3:43:00 PM
From: Jim Roof	Read Replies (1) of 4634

Bill, You mentioned a rumor that was false regarding Biotime's submittal of the NDA by the end of March. At least I remember you saying that it was false. ################################################################ NDA: BERKELEY, Calif.--(BW HealthWire)--March 31, 1998--BioTime, Inc. (NASDAQ:BTIM - news) today announced that it has completed the submission of its New Drug Application (NDA) for Hextend(R), BioTime's proprietary blood plasma volume expander. .... Entire text: biz.yahoo.com ################################################################ You were wrong. It was neither a rumor nor false. It was the company making good on their goal of submission by month's end. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next